Mass General Brigham Cancer Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Mass General Brigham Cancer Institute brings 19 presentations to ASH 2026 in New Orleans. Its research spans myeloproliferative neoplasms, lymphoma in older patients and immune blood disorders. It covers luspatercept for anemia in myelofibrosis and a shortened R-mini-CHOP course for very elderly patients with limited-stage large B-cell lymphoma.
| Organization | ASH 2026 Attendance |
|---|---|
Mass General Brigham Cancer Institute Boston, MA | |
Cancer care and research institute of the Mass General Brigham health system in Boston. | Symposium Fri Dec 11 11:00am–2:00pm Transforming Care for Newly-Diagnosed Multiple Myeloma: Integrating Evidence-Based Innovation into Community Practice Newly diagnosed multiple myeloma care in community clinics, using frailty assessment, dose adjustment to protect quality of life, and new drug formulations. Symposium Fri Dec 11 3:00pm–6:00pm Cases and Conversations: Applying Emerging Evidence to Real-World Care in Myeloproliferative Neoplasms Choosing among new myeloproliferative neoplasm drugs, including Janus kinase and telomerase inhibitors, hepcidin mimetics, and calreticulin-targeted antibodies. Oral Sat Dec 12 2:00pm–3:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 9:30am–11:00am Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Mass General Brigham Cancer Institute
Tell us what you sell and we’ll find the people at Mass General Brigham Cancer Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction